The pharmaceutical landscape is undergoing a transformative shift with the advent of technologies like AI, big data, and IoT, heralding the era of Pharma 4.0. Moreover, given the rising pharma demand, quality pharma stocks Procaps Group S.A. (PROC), Sanofi (SNY), Viatris Inc. (VTRS), Ipsen S.A. (IPSEY), and Teva Pharmaceutical Industries Limited (TEVA) could be solid buys.
The pharma industry is currently witnessing unprecedented growth. Breakthrough therapies launched in the last decade are reshaping patient care. Moreover, spending on medicine growth is driven by both volume and higher-cost therapies, reflecting broader access to medicines with greater clinical value.
